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“Living versus Dead”: The Pasteurian 
Paradigm and Imperial Vaccine Research
pratik chakrabarti
Summary: The Semple antirabies vaccine was developed by David Semple in India 
in 1911. Semple introduced a peculiarly British approach within the Pasteurian 
tradition by using carbolized dead virus. This article studies this unique phase of 
vaccine research between 1910 and 1935 to show that in the debates and labora-
tory experiments around the potency and safety of vaccines, categories like “liv-
ing” and “dead” were often used as ideological and moral denominations. These 
abstract and ideological debates were crucial in defining the final configuration 
of the Semple vaccine, the most popular antirabies vaccine used globally, and also 
in shaping international vaccination policies.
Keywords: Semple, carbolic acid, live vaccine, Pasteur, rage du laboratoire, Ka-
sauli
The development of the Semple antirabic vaccine was a pioneering but 
little known colonial research program. Originally developed by David 
Semple (an officer of the Indian Medical Service, IMS) at the Central 
Research Institute in Kasauli (CRI, India) in 1911, it was the most com-
monly used antirabies vaccine throughout the world and until 2000 the 
only such vaccine used in the developing countries where rabies is wide-
spread. This article studies this unique phase of vaccine research in colo-
nial India between 1910 and 1935. It studies the morality of using dead 
and live vaccines, the laboratory experiments on poor Indian patients, the 
determination of  quantities of brain matter in vaccines, and the domes-
tic and international public health factors, all of which defined the final 
configurations of the Semple vaccine. By studying the history of making a 
vaccine, this article captures the location of Pasteurian bacteriology within 
the larger ideological, political, and ethical history of bacteriology and 
vaccination policy in colonial India.
The author is thankful to the Wellcome Trust for funding the research for this article.
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The existing literature is rich in the analysis of the history of vaccine 
research and production through industrial and laboratory modes.1 It 
has also extensively depicted the moralities of vaccine experiments (on 
animals and humans) and vaccination campaigns.2 This article studies 
the moral debates in vaccine research with regard not to the subjects of 
the experiments but its objects, the germs used in the vaccines. The study 
of the debates around using “live” and “dead” vaccines also challenges 
some of the sociological understanding of the Pasteurian laboratory. 
Bruno Latour has critiqued Louis Pasteur’s engagement with microbes 
and argued that by creating a controlled condition of existence Pasteur 
assumed a position of power. He posed himself stronger than the bacillus 
as well as the farmers, who were then subjected to his method. To chal-
lenge Pasteur’s authoritative “control,” Latour attributed life to the inani-
mate microbes.3 However, this hylozoism does not address the essential 
problem of Pasteurian bacteriology.4 As this article shows, “life” and “liv-
ing” formed the core of Pasteur’s engagements with microbes and were 
essentially constructs. Therefore, by seeking to provide life-like agency to 
these organisms, Latour in effect extended the Pasteurian project rather 
than questioning Pasteur’s role in creating such divides between living 
and the dead microbes.
Rabies is an acute encephalitis caused by a virus that affects hot-blooded 
animals, including humans. It kills by attacking the central nervous sys-
tem. In 1885 Pasteur identified the nervous system as the main target for 
its experimental reproduction and conceived means of attenuating the 
agent by repeated passages through rabbits. Strips of fresh spinal cord 
material taken from rabbits that had died from rabies were exposed to 
dry, sterile air for various lengths of time. This tissue was then ground up 
and suspended in a sterilized broth. This solution was used as a vaccine.5
1. Christoph Gradmann, “Locating Therapeutic Vaccines in Nineteenth-Century His-
tory,” Sci. Context 21 (2008): 145–60; Jonathan Simon, “Monitoring the Stable at the Pasteur 
Institute,” Sci. Context 21 (2008): 181–200; and J. Andrew Mendelsohn, “The Microscopist 
of Modern Life,” Osiris 18 (2003): 150–70.
2. Gerald L. Geison, The Private Science of Louis Pasteur (Princeton, N.J.: Princeton Uni-
versity Press, 1995); Nicholas Rupke, ed., Vivisection in Historical Perspective (London: Croom 
Helm, 1987); and Michael E. Lynch, “Sacrifice and the Transformation of the Animal Body 
into a Scientific Object: Laboratory Culture and Ritual Practice in the Neurosciences,” Soc. 
Stud. Sci. 18 (1988): 265–89.
3. Bruno Latour, Pasteurisation of France (Cambridge, Mass.: Harvard University Press, 
1988), 80–86.
4. For a brilliant critique of this aspect of Latour’s work, see Simon Schaffer, “The Eigh-
teenth Century Brumaire of Bruno Latour,” Stud. Hist. Philos. Sci. 22 (1991): 174 –92.
5. “Pasteur’s Method,” Pioneer Mail and Indian Weekly News, August 12, 1896, 26–27.
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Semple introduced a peculiarly British approach within this Pasteurian 
tradition by using carbolized dead virus, a method he adopted from his 
tutor Almroth Wright’s work on opsonins and vaccine therapy. Historians 
who have worked on Pasteur and the moral and political history of bacte-
riology have referred to dead and living vaccines as well as their medical 
implications but have failed to indicate their therapeutic and ideological 
significance. As a consequence they have often adopted categories like 
“heroic” and “sterile” while discussing live and dead vaccines.6 This not 
only has led to ambiguous understanding of such categories but also has 
given rise to misunderstanding of the side effect from antirabies vaccines 
often associated with live vaccines, namely “laboratory rabies,” a volatile 
issue in Pasteur’s time. This article argues that in these debates and labo-
ratory experiments around the potency and safety of vaccines, categories 
like “living” and “dead” were often used as ideological and polemical cat-
egories rather than scientific ones, which acquired further political and 
ethical significance in colonial vaccination policies. It is this ambiguity that 
holds a key to the development of the Semple vaccine and its application 
in Asia and Africa. The debates around using living and dead vaccines 
refer to the two most important concerns of vaccine research, potency 
and safety. On one hand was the heroic potency of the living and, on the 
other, the sterilized safety of the dead.
Pasteur and the World of the Living
From 1854 Pasteur was concerned with the role of living organisms in caus-
ing fermentation: “[F]ermentation is an act correlated with the life and 
organisation of the yeast cells, not with the death or putrefaction of the 
cells.” This led to his famous assertion, “[N]o fermentation without life.”7
Contemporary Pasteurists were fascinated by these miniscule organisms 
while watching their world under the microscope, the “wondrous workings 
6. Gerald L. Geison, “Pasteur, Roux, and Rabies: Scientific versus Clinical Mentalities,”
J. Hist. Med. & Allied Sci. 45 (1990): 341–65; Kim Pelis, “Prophet for Profit in French North 
Africa: Charles Nicolle and the Pasteur Institute of Tunis, 1903–1936,” Bull. Hist. Med. 51 
(1997): 583–622, esp. 595–96; Ilana Löwy, “From Guinea Pigs to Man: The Development 
of Haffkine’s Anticholera Vaccine,” J. Hist. Med. & Allied Sci. 47 (1992): 270–309; George 
H. Bornside, “Waldemar Haffkine’s Cholera Vaccines and the Ferran–Haffkine Priority 
Dispute,” J. Hist. Med. & Allied Sci. 37 (1982): 399–422; and Derek S. Linton, “Was Typhoid 
Inoculation Safe and Effective during World War I? Debates within German Military Medi-
cine,” J. Hist. Med. & Allied Sci. 55 (2000): 101–33.
7. Keith L. Manchester, “Louis Pasteur (1822–1895)—Chance and the Prepared Mind,” 
Trends in Biotechnology 13 (1995): 511–15, quotation on 513.
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of nature,” their “brilliant” colors, their rhythmic movements resembling 
a “peal of bells,” and their singular pursuit for food through life.8 Pasteur 
applied his theory of fermentation to disease theory to assert that diseases 
caused by living organisms could be treated by the same living organisms 
in an attenuated form. Attenuation of living forms was fundamental to 
the Pasteurian method. Pasteur asserted that his method of partial ster-
ilization without killing the germs was successful due to the control he 
exercised over living forms: “I have kept from them [the microbes], and 
am still keeping from them, that one thing which is above the power of 
man to make. . . . I have kept from them life.”9 In such an enterprise, the 
use of live vaccines appeared both “heroic” and ubiquitously potent. This 
image of valiancy was associated with the vaccination campaigns of the 
late nineteenth century, and live vaccines became a Pasteurian dogma.10
In 1881 Pasteur proclaimed about his anthrax vaccine, “They are living 
vaccines, suitable for cultivation, transferable anywhere without being 
altered.”11
Pasteur and his pupils used live attenuated virus to prepare antirabic 
and other vaccines. Albert Calmette and Camille Guérin developed the 
live tuberculosis vaccine in 1908. In 1892 Waldemar Haffkine developed 
the first cholera vaccine in the Pasteur Institute in Paris. It was a live vac-
cine, which he tested widely in India from 1892 to 1896.12 During his 
journey from Paris to India Haffkine killed the vaccine with carbolic acid 
to preserve it, and on the ship to India he even vaccinated an IMS officer 
with the dead vaccine.13 But once in India, he adhered to the Pasteurian 
notion and reverted to using live vaccines, which, according to historians, 
gave his vaccination campaigns “heroic” and “adventurous” qualities.14
Haffkine preferred live vaccines as he believed that they produced higher 
8. Eliza Priestley, “The Realm of the Microbe,” Nineteenth Cent. 29 (1891): 811–31, quota-
tions on 811, 816, 817, and 831.
9. Quoted in Stephen Paget, Pasteur and After Pasteur (London: Black, 1914), 30.
10. Bornside, “Waldemar Haffkine’s Cholera Vaccines” (n. 6), 408.
11. Anne-Marie Moulin, “Patriarchal Science: The Network of the Overseas Pasteur 
Institutes,” in Science and Empires: Historical Studies about Scientific Development and European 
Expansion, ed. Patrick Petitjean, Catherine Jami, and Moulin (Dordrecht, Netherlands: 
Kluwer, 1992), 307–22, quotation on 309. 
12. Bornside, “Waldemar Haffkine’s Cholera Vaccines” (n. 6), 405.
13. Courtney Clark Manifold, “Report of a Case of Inoculation with Carbolized Anti-
choleraic Vaccine (Haffkine),” Indian Med. Gazette 18 (1893): 101–3.
14. Löwy, “From Guinea Pigs to Man” (n. 6), 298. Bornside described Haffkine’s cholera 
vaccination campaigns with live vaccines as “heroic.” “Waldemar Haffkine’s Cholera Vac-
cines” (n. 6), 409.
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immunity.15 He showed little regard for dead vaccines since he wanted to 
show spectacular success with his vaccine to convince skeptical British offi-
cials.16 This reflected how vaccines were seen during this time, as heroic, 
dramatic, and radical interventions. Alongside this Pasteurian faith in the 
living vaccine there was another emerging tradition, a predominantly Brit-
ish one under Almroth Wright, which used mainly dead vaccines.
Opsonins and Dead Vaccines
Wright, professor of pathology at the army medical school at Netley, 
Hampshire, established a highly successful and productive research group 
between 1892 and 1902 there. This group had a strong colonial charac-
ter as most of them like Semple, George Lamb, William F. Harvey, and 
Lyle Cummins were training to join either the IMS or the bacteriologi-
cal department of the government of India (GOI). Wright broke away 
from the Pasteurian practice of using attenuated viruses as he found that 
killed vaccines were particularly useful for inducing the formation of 
antibodies.17 Wright claimed that such vaccines carried fewer risks and 
were easier to standardize than attenuated live cultures.18 It was Wright 
who for the first time used the dead bacteria as the active constituent of 
his typhoid vaccine. Working with Semple in July 1896, Wright inoculated 
himself and his “volunteers” with different dilutions of heated cultures 
of typhoid bacilli and used agglutination tests to measure any enhanced 
immunity produced. When he came to India as the head of the Plague 
Commission in 1897 he experimented with this vaccine in some of the 
garrisons.19 During World War I, heat-killed antityphoid vaccines prepared 
by Wright, Richard Pfeiffer, and Wilhelm Kolle came to be regarded as 
safe and dependable.20
15. Löwy, “From Guinea Pigs to Man” (n. 6), 299; and Bornside, “Waldemar Haffkine’s 
Cholera Vaccines” (n. 6), 403.
16. Löwy, “From Guinea Pigs to Man,” (n. 6), 300.
17. Leonard Colebrook, “Almroth Edward Wright. 1861–1947,” Obit. Notices Fell. Roy. 
Soc. 6 (1948): 297–314.
18. “Sir Almroth Wright,” Brit. Med. J. 1 (May 1947): 646–47, 647. According to Michael 
Worboys, this move to using dead vaccines established Wright’s approach to immunity as 
that of a physiologist rather than a bacteriologist. Michael Worboys, “Almroth Wright at 
Netley: Modern Medicine and the Military in Britain, 1892–1902,” in Medicine and Modern 
Warfare, ed. Roger Cooter, Mark Harrison, and Steve Sturdy (Amsterdam: Rodolpi, 1999), 
77–97, esp. 88. 
19. “Sir Almroth Wright” (n. 18), 647.
20. Linton, “Was Typhoid Inoculation Safe?” (n. 6), 101–33.
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However, Wright had adopted dead vaccines not just for safety. In 1902 
he started his work on vaccine therapy—which stressed that vaccines 
could be used to stimulate the natural resistance of the individual body 
and not just as a prophylactic agent.21 His vaccine program was thus more 
for curative purposes than prophylactic.22 The basis of this was Wright’s 
theory of opsonization: that a patient who suffered from a particular 
infection had an abnormally low opsonic index,23 in which dead vaccines 
became particularly useful as he believed that they could cure as well as 
prevent disease.24 Wright believed that dead bacteria vaccines could be 
used to stimulate the natural resistance of the individual body as it could 
enhance the production of opsonins and patients could fight their infec-
tion more effectively.25 Semple followed Wright in his own work on the 
vaccine therapy and opsonic index for his research on enteric fever in 
Kasauli. Following Wright, he sought to develop vaccines that could be 
both prophylactic as well as therapeutic. He sterilized his vaccines with 
0.5 percent carbolic acid.26
David Semple and His Antirabies Vaccine
Semple’s choice of carbolic acid was significant. An antiseptic derived 
from coal, carbolic acid had a peculiarly British heritage and an industrial 
machismo. Joseph Lister, who “championed” it,27 saw it being used as a 
21. John R. Matthews, “Major Greenwood versus Almroth Wright: Contrasting Visions of 
‘Scientific’ Medicine in Edwardian Britain,” Bull. Hist. Med. 69 (1995): 30–43, esp. 35–36. 
22. Wai Chen, “The Laboratory as Business: Sir Almroth Wright’s Vaccine Programme 
and the Construction of Penicillin,” in The Laboratory Revolution in Medicine, ed. Andrew 
Cunningham and Perry Williams (Cambridge, UK: Cambridge University Press, 1992), 
245–94, esp. 253.
23. A substance called opsonin which is present in the patient’s serum. 
24. This was popularized by Wright and Alexandre Besredka. See Matthews, “Major 
Greenwood” (n. 21); and Ilana Löwy, “‘The Terrain Is All’: Metchnikoff’s Heritage at the 
Pasteur Institute, from Besredka’s ‘Antivirus’ to Bardach’s ‘Orthobiotic Serum,’” in Greater 
Than the Parts: Holism in Biomedicine 1920–1950, ed. Christopher Laurence and George Weisz 
(New York: Oxford University Press, 1998), 257–82.
25. Matthews, “Major Greenwood” (n. 21), 35–36; and Chen, “Laboratory as Business” 
(n. 22), 264 –66.
26. David Semple, “A Preliminary Note on the Vaccine Therapy of Enteric Fever,” Lancet
173 ( June 1909): 1668–75, esp. 1668–69. According to him, the principle of opsonic index 
helps “in setting in motion the machinery which elaborates the products of immunisation.” 
Ibid., 1669.
27. Michael Worboys, Spreading Germs: Disease Theories and Medical Practice in Britain, 
1865–1900 (Cambridge, UK: Cambridge University Press, 2000), 81.
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disinfectant in Carlisle for the treatment of sewage.28 He suggested that it 
could be used to kill the germs before they got a footing in the body or in 
the wound.29 Wright adopted the acid to kill the viruses for his vaccines, 
and Semple developed his own carbolized dead vaccines for typhoid in 
India.30 In 1911 he used the same principle for developing his antirabic 
vaccines. He had started his work on rabies from Wright’s premises of 
the opsonic stress on blood and vaccine therapy; in using the blood of an 
animal infected with rabies to protect other animals against the disease.31
During 1903–4 Semple treated two hundred patients in Kasauli with anti-
rabic serums as a preliminary to the usual vaccine treatment. Although he 
found good results, it was not clear whether the results were due to the 
serum treatment only.32 However, by 1911 Semple had given up his work 
on serum therapy and was working on a more conventional antirabic vac-
cine. This was perhaps because he discovered that serum therapy could 
not work on its own and had opted for a simpler single treatment method 
with conventional vaccines.33 He developed his carbolized vaccine at the 
CRI from the brains of rabbits deliberately infected and then killed.34
Semple’s carbolized antirabic vaccine brought about a confluence of 
Pasteurian and British researches on germs and at the same time broke 
away from both. It departed from the Pasteurian tradition of using a 
dry-cord-attenuated antirabies vaccine. At the same time, his carbolized 
dead vaccine was no longer developed for Wright’s principles of opsonins 
and vaccine therapy but for safety and easy transportability in a tropical 
country. Semple highlighted three advantages of the vaccine: It was safe in 
terms of postvaccinal complications: “[K]nowing that it is a dead vaccine 
we can dismiss any doubts as to the possibility of its producing the disease 
28. Christopher Lawrence, “Lister, Joseph, Baron Lister (1827–1912),” in Oxford Diction-
ary of National Biography (Oxford: Oxford University Press, 2004), http://www.oxforddnb.
com/view/article/34553 (accessed April 2, 2008); and William Watson Cheyne, “Lister, the 
Investigator and Surgeon,” Brit. Med. J. 1 (May 1925): 923–26, esp. 923.
29. William Kingston, “Antibiotics, Invention and Innovation,” Res. Policy 29 (2000): 
679–710, esp. 680.
30. Semple, “Preliminary Note” (n. 26), 1668–69.
31. David Semple, “On the Preparation and Use of Antirabic Serum, and on the Rabicidal 
Properties of Patients after Undergoing Antirabic Treatment; Also a Note on the Blood of 
a Patient Suffering from Hydrophobia,” Lancet 171 ( June 1908): 1611–18.
32. Ibid., 1613.
33. David Semple, The Preparation of a Safe and Efficient Antirabic Vaccine: Scientific Mem-
oirs by the Officers of the Medical and Sanitary Departments of the Government of India (Calcutta: 
Superintendent Government Printing, 1911), 27.
34. Ibid., 28.
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which it is intended to prevent.”35 It could be sent to distant places in the 
Indian empire without reducing its efficiency.36 Third, vaccine produc-
tion could be standardized. It could be produced at one central Pasteur 
Institute and then sent to the rest of India.37 With his new antirabies vac-
cine, Semple asserted that live vaccines were a thing of past: “No person 
would be justified in using a living staphylococcus, or a living streptococ-
cus vaccine, when dead vaccines prepared from these germs answer every 
purpose.”38 The Pasteurian logic of the ubiquity of living vaccines was 
now reversed. In Semple’s hand, in a tropical country like India where 
bacteriological research was deemed ideal only in the salubrious climate 
of the hills where the Indian Pasteur Institutes were built by the British, 
carbolized dead vaccines provided a new dimension. Semple’s antirabic 
vaccine became popular and highly acclaimed. Pardey Lukis, the director 
general of the IMS (DGIMS), claimed, “The Pasteur treatment of this dis-
ease [rabies], so far as India is concerned, has been revolutionized during 
the past few years by Semple’s discovery.”39 The Lancet praised Semple’s 
vaccine as “safe and efficient.”40 This seemed the ideal vaccine for India 
as it could be sent to different parts of the country.
Since dead vaccines appeared particularly suitable to be transferred 
over long distances in tropical climates, they were also considered ideal 
to serve an important medical and political contingency in India: decen-
tralization of vaccine treatment. Semple’s vaccine in hermetically sealed 
ampoules could be transported to and stored in distant places without 
detriment to its quality.41 In north India the railway center at Allahabad 
was opened in 1924, as the first out center supplied with vaccines from 
Kasauli for antirabic treatment, and centers at Lahore and Rawalpindi 
were opened a year later. In western India, J. Morrison (assistant director, 
Bombay Bacteriological Laboratory) announced that the government had 
adopted the policy of “bringing antirabic treatment nearer the home of 
those who need it.”42 By 1923 carbolized antirabies vaccine was issued to 
35. Ibid., 31.
36. Ibid., 29.
37. Ibid., 4. His recommended dosage was dilutions of 4 percent and 8 percent rabies 
virus in 1 percent carbolic acid.
38. Ibid., 1.
39. “Opportunities for Original Research in Medicine in India,” J. Roy. Soc. Arts 65 (1917): 
391–95, quotation on 392.
40. “A Safe and Efficient Antirabic Vaccine,” Lancet 178 ( July 1911): 173.
41. William J. Webster, Rabies and Antirabic Treatment in India (Delhi: Manager of Publi-
cations, 1946), 6.
42. Morrison to director, Bombay Bacteriological Laboratory, May 8 1923, “Anti-rabic 
Treatment: Opening of Additional Centres,” General Department, G.D. file no. 4761 (I), 
ff, 5–7, Maharashtra State Archive, Mumbai, India.
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various centers in north and south India. Decentralization had an impact 
on awareness about the disease and treatment. In 1925 the Pasteur Insti-
tute, Coonoor,  reported a decrease in the number of deaths from rabies 
from the previous year. The number of patients at the local centers also 
increased.43
However, this shift to dead antirabies vaccines was not just an Indian 
or a tropical phenomenon. A similar move took place in Europe as well, 
but for a very different rationale. Here the main reason for the shift was 
that Pasteur’s live vaccine was linked to a peculiar but dreaded disease, 
“laboratory rabies,” or rage du laboratoire, a form of rabies apparently pro-
duced from the vaccine itself in the laboratory. Since the days of Joseph 
Meister, Pasteur’s antirabies methods were hotly debated by scientists and 
antivaccinationists who claimed that his vaccines killed more people than 
they cured.44 In 1886 Michel Peter presented a clearer image of “labora-
tory rabies” to the scientific world when he presented to the Academy of 
Medicine in Paris details of eleven cases where patients had died from the 
“poison” of Pasteur. He suggested that Pasteur’s live vaccines carried the 
germs of rabies, famously labeling the process the “intentional inocula-
tion with M. Pasteur’s ‘laboratory rabies.’”45 Peter’s critique shook the very 
foundation of Pasteurian vaccine, suggesting that scientists had failed to 
“control” the living microorganisms as Pasteur had asserted. As a result 
“laboratory rabies” became symbolic of Pasteurian failures. It was also 
used by scientists as well as historians to refer to patients who had died 
with signs of paralysis after receiving the Pasteur treatment.46
Laboratory rabies was associated with live vaccines, the keystone of 
Pasteur’s method. The association appeared logical. A problem identi-
fied by scientists with living vaccines was that they multiplied in the body: 
“[T]he multiplication of a living rabies virus intended as a prophylactic 
vaccine would mean hydrophobia and death to the person inoculated.”47
The concern about living vaccines was of particular concern in the con-
text of rabies as they contained nerve cells that could lead to neurological 
complications.48 These fears about inoculating with living nerve cells and 
43. “India,” Brit. Med. J. 2 (October 1925): 765–66.
44. Toby Gelfand, “11 January 1887, the Day Medicine Changed: Joseph Grancher’s 
Defense of Pasteur’s Treatment for Rabies,” Bull. Hist. Med. 76 (2002): 698–718; and Geison, 
“Pasteur, Roux, and Rabies” (n. 6).
45. Bryan Benjamin, “A Pasteur Institute for India,” 373–74, Home-Medical, August 1894, 
P/4554, Asia Pacific and Africa Collections, British Library, London (hereafter APAC).
46. Gelfand, “Day Medicine Changed” (n. 44), 710.
47. Semple, Preparation of a Safe and Efficient Antirabic Vaccine (n. 33), 2.
48. John W. Cornwall and W. A. Beer, “On the Occurrence of Paralysis after Treatment 
with Antirabic Vaccine,” Indian J. Med. Res. 13 (1926): 467; Cornwall, “Recent Advances of 
Knowledge in Connection with Rabies,” Indian Med. Gazette 42 (1907): 121.
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laboratory rabies took center stage at a very important forum, the First 
International Rabies Conference, convened by the League of Nations 
and held in Paris in April 1927. Directors of all major antirabies institutes 
of the world attended the conference, and John Taylor (director of the 
Pasteur Institute in Rangoon, Burma) represented India.49
Fear of the Living
The conference was the finest hour of Semple’s vaccine. The discussion 
centered around methods of treatment and accidents from antirabies 
treatment worldwide.50 In his presentation Taylor showed statistics for all 
the Indian Pasteur Institutes, around 170,000 cases, which easily outnum-
bered those of any other country. In India the cases were also much more 
severe.51 Most importantly, Taylor showed that paralytic accidents hardly 
occurred with carbolized dead vaccines.52 The dead carbolized vaccine 
now appeared to be the new hope for Europe.
The Indian antirabic experience received high commendation even 
from the core Pasteurian group. A. C. Marie, professor at the Pasteur 
Institute in Paris, found the results obtained by Semple’s method to be 
“most significant.”53 Paul Remlinger, director of the Pasteur Institute in 
Morocco, who analyzed postvaccinal paralytic cases in all Pasteur Institutes 
of the world using various methods, found Semple’s method to be the 
safest and considered that “the elucidation of this fact appears to us to be 
the most important lesson provided by the Conference”54 (Table 1).
The conference also concluded that the dead carbonized and ether-
ized vaccines were best suited for large-scale production with the growing 
popularity of antirabies vaccination throughout the world.55 The resolu-
49. H. G. Dennehy to Under Sec of State, December 9, 1926, Economic and Overseas 
Department Papers, L/E/7/1465, 1, APAC.




53. A. C. Marie, Paul Remlinger, and H. Vallée, International Rabies Conference Held at the 
Pasteur Institute, Paris, from April 25th to 29th, 1927 (Geneva: League of Nations, 1927), 48.
54. Ibid., 97–98. Remlinger’s own work was mainly on the paralytic accidents from rabies; 
see George M. Baer, ed., The Natural History of Rabies (New York: CRC Press, 1991), 15–16; 
Remlinger, “Accidents paralytiques au cours du traitement antirabique,” Ann. de 1’Inst. Pas-
teur 19 (1905): 625; “Rage experimentale de la souris et du rat,” C.R. Soc. Biol. 56 (1904): 42; 
and “La rage de laboratoire,” Bull. Acad. Med. Paris 113 (1935): 836.
55. “Anti-rabies Vaccination and the Public Authorities,” in Marie, Remlinger, and Vallée,
International Rabies Conference (n. 53), 154 –57.
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Table 1. Paris conference (1927) worldwide antirabic vaccine paralysis data. 
50
Table 1
Table 1. Paris conference (1927) worldwide antirabic vaccine paralysis data. Source:
A. C. Marie, Paul Remlinger, and H. VallŽe, International Rabies Conference Held at
the Pasteur Institute, Paris, from April 25th to 29th, 1927 (Geneva: League of
Nations, 1927), 83Ð84.
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Nations, 1927), 83–84.
ions passed at he conference supported dead vaccines, c rbolized fol-
lowing Semple’s method and etherized as done more recently by Adolph 
Hempt.56 The conference also resolved that comparative tests on a large 
scale should be carried out in certain selected institutes with the two vac-
cines. Kasauli was to be one of such sites.57 Under Secretary of State for 
India Edward J. Turner received Taylor’s report warmly in London and 
forwarded it to Delhi, suggesting that the GOI should publish a summary 
of it in Indian medical journals.58
Matters in India, however, seemed to be on a somewhat different note. 
In the face of this enthusiasm about the dead carbolized vaccine in Lon-
don, the public health commissioner (PHC) for India, J. D. Graham, wrote 
to the India Office (London) recommending “against [the] immediate 
publication of Taylor’s report . . . in view of certain local factors.”59 In his 
56. Marie, Remlinger, and Vallée, International Rabies Conference (n. 53), 7. 
57. Ibid., 8. 
58. Edward J. Turner to the Sec, Govt of India, July 15, 1927, 6, Economic and Overseas 
Department Papers, L/E/7/1465, APAC.
59. “Extract from Private a Letter from Col. Graham to Mr Donaldson,” 22 September 
1927, ibid.
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subsequent note Graham added that despite the sanction from Europe, 
in India the carbolized dead vaccine was not considered the final word, 
and at the Pasteur Institute in Kasauli the director, John Cunningham, 
was involved in comparative tests with etherized and carbolized vaccines, 
which was one of the recommendations of the Paris conference.
However, in Kasauli, Cunningham was in fact experimenting with live 
vaccines attenuated by ether, contrary to the Paris resolutions, which rec-
ommended using dead vaccines, etherized or carbolized.60 The rationale 
for Cunningham’s research was different as well from the Paris resolu-
tions. To defend his project he had invoked the old Pasteurian doctrine 
of the potency of live vaccines, suggesting that the Indian Pasteur Insti-
tutes faced much greater numbers of severe cases than those in Europe 
and therefore required a more potent live vaccine.61 At the same time he 
asserted the autonomy of Indian scientific research from European trends: 
“India must work out her own antirabic problem without too much slav-
ish deference to European ideas.”62 Although the Paris resolutions had 
instructed experimentation on two types of dead vaccines, etherized and 
carbolized, Cunningham in Kasauli had created his own divide between 
the live and the dead, that between etherized and carbolized, and had 
adopted the former as a live vaccine.
This new development had an immediate implication for the antirabies 
vaccination policy of the GOI. The ongoing decentralization of rabies 
treatment had to be stopped as Cunningham insisted that all patients 
needed to be sent to Kasauli to facilitate the experiments on a large scale.63
This exposed the contrasting political interests involved in vaccination 
policy in India. The India Office in London, keen to highlight the success 
of vaccine research and vaccination in India, internationally and to the 
British public, reacted strongly to this change. The Under Secretary of 
State Arthur Hirtzel wrote to the GOI that he was unable to understand 
why authorities in India still wanted to continue the experiments, cen-
tralize research, and send all the patients to the remote hills when a safe 
and acclaimed vaccine was available. This would mean that many patients 
could die without treatment: “[T]he suggestion seems to me to confuse 
means & ends. After all, human life is something, even in India!”64 The 
India Office was sensitive about human experimentations in India due to 
the pressures of British antivivisectionists and humanitarians who kept a 
60. Graham to Donaldson, New Delhi, November 16, 1927, 2–3, ibid.
61. Ibid., 5.
62. Quoted by Graham, ibid., 3.
63. Ibid., 4 –5.
64. Arthur Hirtzel (Under Sec of State) to the Medical Adviser, January 17, 1928, ibid.
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keen eye on the activities of the Indian Pasteur Institutes. Laboratories 
and medical experiments in the colonies were sensitive issues in London, 
a sensitivity that authorities in India did not always share.65
Scientific opinion in India too was firmly in support of the Semple vac-
cine.66 Directors of the other Indian Pasteur Institutes who had already 
made plans for decentralization and mass inoculation with the Semple 
vaccine were skeptical of Cunningham’s experiments in Kasauli. John 
Morrison, director of the Shillong Institute, wrote to Smith (the medical 
advisor in London) about the “human side” of the question, that lack 
of treatment in remote areas would lead to high mortality, a factor that 
those making policy from Shimla had “not done justice to.”67 He enclosed 
transcripts of debates at the Assam legislative assembly that highlighted 
the growing pressure on the institutes and the provincial government to 
decentralize treatment.68
However, the elite group in Shimla, comprising influential medical 
personnel of the GOI, had a different point of view. Even before the Paris 
conference, a decision was taken by the GOI to stop decentralization of 
rabies vaccination in light of Cunningham’s new experiments in Kasauli. 
In 1925 the Indian PHC reported that Cunningham would undertake 
experiments with the etherized vaccine in Kasauli and “pending the 
results . . . no new centres, military or civil, should be established in the 
plains.”69 In September 1926 a Medical Committee comprising T. H. 
Symons (DGIMS), Graham (PHC), John K. S. Fleming (deputy DGIMS), 
S. R. Christophers (director, CRI, Kasauli), and Cunningham (director, 
Pasteur Institute, Kasauli) met in the office of the DGIMS in Shimla.70
They decided that no new centers were to be opened to facilitate Cunning-
65. Pratik Chakrabarti, “Beasts of Burden: Animals and Laboratory Research in Colonial 
India,” Hist. Sci. 48 (2010): 125–51.
66. William F. Harvey and H. W. Acton, “An Examination into the Degree of Efficacy 
of Antirabic Treatment,” Indian J. Med. Res. 9 (1923): 853; R. Knowles, “Some Problems in 
Rabies,” Indian Med. Gazette, 67 (1927): 389–91.
67. Morrison to Smith, January 10, 1928, Economic and Overseas Department Papers, 
L/E/7/1465, APAC.
68. “Extract from Official Report of the Assam Legislative Council Debates,” April 9, 
1928, 482, ibid.
69. Annual Report of the Public Health Commissioner with the Government of India, 1925, vol. 
1, 61–62, V/24/3659, APAC.
70. “Minutes of a Meeting of a Medical Committee held in the office of the Director-
General, Indian Medical Service, on September 28 at 11 am, ‘Inadvisability of Extending 
Anti-rabic Treatment by Present Carbolised Vaccine to District Areas in India until Results 
of Investigations Are Known,’” Department of Education Health and Land, Medical Branch, 
1926, 95–96 B, 6, National Archive of India, New Delhi (hereafter NAI).
400 pratik chakrabarti
ham’s experiments with live vaccines. They also anticipated that the 
forthcoming conference in Paris with its strong Pasteurian legacy would 
pronounce emphatically in favor of the etherized live vaccines.71 At this 
stage this group in India underestimated how much the fear of paralysis 
and the living vaccine had gripped contemporary European scientific 
opinion. But the question remains, why then did the GOI send Taylor to 
Paris with the positive results of the Semple vaccines? To understand this, 
we have to focus closely on the ongoing experiments in Kasauli under 
Cunningham.
The Revival of the Live Vaccine
John Cunningham (Figure 1) was a Scottish physician who joined the 
IMS in 1905 and after working in various laboratories in India served as 
director of the King Institute in Madras (1919–26) and that of the Pasteur 
Institute in Kasauli from 1926.
71. Ibid., 6–7.
Figure 1. John Cunningham. Source: Edinburgh University Library, Special Col-
lections Department, “John Cunningham in Brewery Garden,” Kasauli 1916, Gen 
2004 B.5 XX/3, JC papers (n. 73).
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Anderson G. McKendrick (1876–1943), another IMS officer and a 
friend, who was then working at the Edinburgh Research Laboratory, 
introduced Cunningham to etherized vaccine in 1925.72 McKendrick was 
the director of the Pasteur Institute at Kasauli between 1914 and 1920, 
when he concentrated on rabies research. In Britain, he subsequently 
became an authority on rabies. He was also a delegate at the rabies con-
ference in Paris.
McKendrick was keen that Cunningham should try the new ether 
method developed by Hempt and G. P. Alivisatos, perhaps to serve his own 
interests in collecting statistics on antirabies vaccination. Throughout the 
1920s he collected and compiled data about various antirabic methods 
used in different institutions worldwide. Soon after Cunningham joined 
PIK as director, McKendrick sent him a survey of recent literature encour-
aging him to try the new ether method.73 McKendrick himself expressed 
no particular preference for either ether or live vaccines. At the Paris 
conference he expressed the view that there was no significant difference 
in terms of mortality among Pasteur’s original dried cord, Hoyges’s dilu-
tion, and Semple’s carbolized vaccines.74
While McKendrick was interested in the new ether method for col-
lecting statistical data, Cunningham adopted the etherized vaccine with 
new enthusiasm and conviction. He believed in the orthodox Pasteurian 
dogma that a live vaccine had greater potency and felt it was ideal for 
severe Indian cases. He came to this conclusion particularly after reading 
Hempt’s early publications.75 Soon after becoming the director of PIK, 
Cunningham started his experiments with etherized vaccines with patients 
with the most severe injuries.76 He informed Graham about the new ether 
method and added that although in India dead carbolized vaccine had 
been adopted, institutes in Europe were “using virus which is not dead 
but attenuated by ether.”77
72. McKendrick was a mathematician, epidemiologist, and army officer belonging to the 
IMS, director Pasteur Institute, Kasauli (1914 –20). He also served as the superintendent of 
the Research Laboratory, Royal College of Physicians, Edinburgh (1920–41).
73. McKendrick to Cunningham, December 13, 1925, E. 15, Papers and correspondence 
of John Cunningham, 1880–1968, reference code: GB 0237 Gen. 2004, 15 boxes, Special 
Collections, Edinburgh University Library, Edinburgh (hereafter JC papers).
74. “Further Note on the Antirabic Treatment Position,” L/E/7/1465, 1–6, APAC.
75. “Notes on Literature on Rabies,” A. 14, JC papers.
76. Ether Experiments, I, Resistance to Ether 1926–1927, E. 3, Ether Experiments, III. 
Human Cases Treated with Ether Virus, 1926–7, Note 8, October 1926, “It has been decided 
to treat the worst human cases attending the Institute with ether vaccine.” E. 5, JC papers.
77. Cunningham to Graham, copy to John K. S. Fleming, secretary, Pasteur Institute of 
India, January 22, 1926, E. 15, ibid.
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Cunningham’s preference for ether was as significant as Semple’s 
choice of carbolic acid. The two attenuating agents had distinct histori-
cal trajectories. While carbolic acid was an antiseptic from Carlisle with 
a Listerian tradition, ether was an anesthetic with a Pasteurian lineage.78
It was originally used by Pasteur for his rabies vaccine experiments and 
then by Remlinger and Roux.79 To Cunningham, ether seemed to have 
a special characteristic: “[T]reatment with ether removes the toxic sub-
stance, which is responsible for post treatment paralysis.”80
Soon after he started, Cunningham received news of a suspicious death 
of a British subaltern named Norman following treatment with carbolized 
vaccine.81 His laboratory notes show reports of several more patients suf-
fering from similar postvaccinal paralysis.82 This led him to express his 
doubts to Graham. He now wanted to begin large-scale experiments with 
the ether-attenuated virus and also centralization of vaccination in his 
laboratory in Kasauli.83
Cunningham was also suspicious of evidence of the early success of 
carbolized vaccine in Indian institutes. He wrote to Graham that he could 
not find any original report of Semple’s experiments in Kasauli.84 After 
searching in Shimla Graham found some confidential notes about the 
original experiments of 1911–12 conducted in Kasauli, which were, as he 
wrote to Cunningham, “extremely interesting reading” and that “paralytic 
complications ensued from time to time.”85
Cunningham reported this to H. W. Acton (director of the Calcutta 
School of Tropical Medicine) and the new evidence with Semple’s vaccines 
that he had come across where even 1 percent carbolized vaccines caused 
paralysis.86 He also wrote to Fleming (deputy DGIMS and secretary of the 
Pasteur Committee of India) challenging the policy of decentralization 
by using carbolized vaccines: “No one can claim, however, that carbolised 
vaccine . . . is the last word in antirabic treatment.”87 He pointed out that 
78. The colorless, light, volatile liquid (C4H10O) resulting from the action of sulfuric 
acid upon alcohol.
79. Lise Wilkinson, “The Development of the Virus Concept as Reflected in Corpora of 
Studies on Individual Pathogens. 4. Rabies––Two Millennia of Ideas and Conjecture on the 
Aetiology of a Virus Disease,” Med. Hist. 21 (1977): 15–31, esp. 29.
80. Cunningham to Graham, January 22, 1926, E. 15, JC papers.
81. W. Keyworth to King, Mardan, March 3, 1926, E. 6, ibid.
82. Patient postcard to the director, Pasteur Institute, Kasauli, January 14, 1926, ibid.
83. Cunningham to Graham, March 2, 1926, ibid.
84. Cunningham to Graham, August 26, 1926, E. 15, ibid.
85. Graham, Office of DGIMS to Cunningham, September 14, 1926, ibid.
86. Cunningham to Acton, November 3, 1926, ibid.
87. Cunningham to Fleming, September 16, 1926, ibid.
The Pasteurian Paradigm 403
recent work in Europe by Alivisatos, Hempt, and Busson with etherized 
vaccines had shown better mortality rates. According to Cunningham, the 
etherized vaccine was live and needed to be prepared every day in the 
laboratory, which required the treatment to remain centralized.
The issue of centralization reflected an important character of medical 
research in British India. Imperial medical research in India commenced 
in the isolated hill-top laboratories. Cunningham’s project provided a new 
impetus to the logic of medical research in the Indian Pasteur laborato-
ries, which were developed as elitist and rarefied imperial institutions far 
from the bustling and clamorous tropical plains. Cunningham believed 
that with the impending decentralization, the Indian Pasteur laboratories 
would become redundant: “[A] very important duty of the Government 
of India to see that such an Institute does exist where new methods can 
be tested and antirabic research carried on. For this purpose a certain 
number of patients to be treated is a necessity and the total cessation 
of such cases would immediately put the Institute out of touch with the 
most important side of antirabic world.”88 Therefore, the opposition to 
decentralize was not just to test live vaccines but also to retain the Pas-
teur Institute as the experimental and imperial headquarter of medical 
research in India. This provided a new rationale to the GOI to sustain the 
remote Pasteur Institutes, a policy that increasingly came under criticism 
from Indian nationalists.89
Cunningham’s plans and experiments with the etherized vaccines, 
however, soon received a setback. In January 1927 he was informed that 
dafadar (Indian cavalry) Kalyan Singh developed severe paralysis after 
being treated by etherized vaccine at Kasauli. The civil surgeon treating 
him reported his horrific death to Cunningham: “The patient was lying 
propped up on pillows with flushed face upon which was an expression of 
anxiety and fear” and added that he had suffered from “complete flaccid 
paralyses.”90 Cunningham came across other similar cases that he reported 
to Fleming but was careful not to link them to the dreaded “laboratory 
rabies”: “The first point to make clear is that this was not a case of ‘rage 
laboratoire.’”91 He suggested that the paralysis was due to foreign nerve 
tissue and was common in all antirabic treatment. But his firm faith in the 
88. Cunningham to the Secretary, Pasteur Institute of India, September 1, 1926, 1–8, 
ibid.
89. David Arnold, Science, Technology and Medicine in Colonial India (Cambridge, UK: 
Cambridge University Press, 2000), 199.
90. Civil surgeon, Jodhpur to Cunningham, January 27, 1927, E. 6, JC papers.
91. Cunningham to Fleming, January 4, 1927, 1–4, E. 15, ibid.
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ether vaccine had been shaken, and he suggested a tactical retreat, that 
ether vaccines should be used in Kasauli only for severe cases.
In February 1927 Cunningham was faced with the forthcoming Paris 
conference, when the complications with the etherized vaccine became 
known. He wrote to McKendrick requesting his support at the confer-
ence.92 Cunningham had one more important revelation to make to Mc- 
Kendrick. He had found that the original fixed virus with which he worked 
in Kasauli was so weak that it actually died when immersed in ether and 
could not be attenuated as done by Hempt and Alivisatos in Europe. In 
effect, he had experimented with a practically dead etherized vaccine.93
This meant that he could not really suggest the advantages of a live ether-
ized vaccine apart from the fact that even the dead etherized vaccine led to 
paralysis. Therefore, at the time of the Paris conference Cunningham was 
in an ambiguous position and did not send any details of his experiments. 
He hoped that the conference would vote in favor of the new European 
etherized vaccine so he could continue his research.
“Living versus Dead”
The Paris conference led to a period of intense experiments by Cun-
ningham in his remote Kasauli laboratory with live vaccines amid grow-
ing domestic and international scientific and political pressures, which 
favored dead vaccines. The developments of the three years 1927–29 
shaped the final configurations of the vaccine and also the future of 
Indian antirabies vaccination policy. As we shall see, despite clear posi-
tioning among scientists about live and dead vaccines, there remained 
a range of ambiguity about live and dead vaccines. This was particularly 
due to the fact that there were several variables involved in the produc-
tion of vaccines, like the strength of the virus fixe, the time and degree of 
attenuation, and the nature and strength of the attenuating agent. Thus, 
in Kasauli following the methods of Hempt and Alivisatos for preparing 
a living etherized vaccine, Cunningham found his vaccine to be dead. In 
Pasteurian research, categories like dead and living were used as moral 
claims and prejudices. No consistent scientific category or experimental 
method was defined to distinguish one from the other, which were essen-
tially differences in degrees of attenuation.
92. Cunningham to McKendrick, February 9, 1927, 3–4, E. 15, ibid. Cunningham also 
wrote to McKendrick that although Taylor, who was on leave in England, was to represent 
India, “[h]e does not know the ins and outs of the matter as far as Kasauli is concerned, 
however, and so you will have to stand up for our opinions there.” Ibid.
93. Ibid.
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McKendrick clearly had a difficult task in Paris. On one side were the 
Pasteur hardliners like Roux and Calmette who still favored the original 
dry cord method and live vaccines; on the other were the new breed of 
scientists convinced of the benefits of the dead carbolized and etherized 
vaccines. He found the conference divided in two camps; as he wrote to 
Cunningham, “[T]he question is living versus dead.”94 In the debates 
there the etherized vaccine was clearly considered dead, as he wrote that 
the new trend was to develop vaccines that were “[d]ead including both 
carbolized and etherized. . . . Kill by any means and get the results.”95
After a chat with Hempt, McKendrick realized that Hempt too had turned 
toward dead vaccines to avoid cases of postvaccination paralysis.96 But he 
rejoiced at the fact that the original dry cord method of Pasteur received 
a decisive blow due to postvaccinal paralysis. Even those working in the 
Paris Institute now seemed to prefer dead vaccines for the fear of paraly-
sis: “[I]t is dead vaccine that all are striving after though they may not 
admit it.”97 The Pasteurian Remlinger seemed to be torn between two 
worlds; in his researches in Morocco he had come across several cases of 
paralysis with dried cord vaccines and yet faced the Pasteurian hardliners 
in Paris who insisted on the original method: “Remlinger looked to me 
like a soul in purgatory. His reason and his sentimentality were pulling 
in different directions.”98
Back from the conference McKendrick reminded Cunningham that 
there was an open field to make important contributions from the massive 
experiments possible in India: “[W]hen the next conference comes on, 
say in 3 or 4 years. . . . From the international point of view India stands 
in a unique position from its experience of this one disease ‘Rabies.’ 
Rabies may not be economically as important to India as say Malaria. But 
regarding Malaria India is a small unit, regarding Rabies India stands out 
prominent. Think that over. You cann’t [sic] afford to neglect the shop 
window.”99
India provided the scope to define the new dead vaccine, etherized or 
carbolized. Cunningham interpreted this as encouragement to continue 
his research with live etherized vaccines. He had retained his faith and 
fascination with the living vaccine, something he had actually not been 
able to experiment with owing to the weakness of the Kasauli strain. He 







noted that the French scientists still believed that living vaccines, although 
hazardous, were more potent and decided that that is where his future 
contribution in antirabies research would be, particularly for India where 
cases were much more severe.100 This is how he arrived at a position so 
contradictory to the Paris resolutions in 1927.
Following the conference, Cunningham resumed his comparative 
researches on live and dead vaccines (Figures 2 and 3). Now he could also 
start experiments with the fresh fixed virus sent by Calmette from Paris, which 
seemed to remain alive after being etherized. His experiments with the two 
methods were in favor of Alivisatos, in terms of mortality rates (Table 2). Two 
facts are evident from Table 2. First, even the so-called living vaccines showed 
figures of mortality. Second, the better results were with Alivisatos’s method, 
which contained larger quantities of brain substance than Hempt’s.101
100. Cunningham to McKendrick, July 1, 1927, ibid.
101. Ibid., 15.
102. Carl Prausnitz to Cunningham, August 19, 1927, E. 18, ibid
103. Prausnitz to Cunningham, October 24, 1927, ibid.
Table 2. Cunningham’s experiments with live vaccines, 1927: Hempt and Alivisatos.
Methods               Total treated               Total death               Percentage deaths
Alivisatos 169 4 2.3
Hempt 66 4 6.0
Total 235 8 3.4
Source: Cunningham, “Note on the Present Position of Antirabic Treatment with 
Reference to the Policy To Be Adopted in the Future,” August 18, 1927, 13–14, E. 17, JC 
papers (n. 73).
While Cunningham was conducting his experiments in Kasauli he 
received correspondences from scientists in Europe interested in the 
Semple vaccine. In August 1927 Carl Prausnitz (1876–1963, German bac-
teriologist), who was impressed by the success of the carbolized vaccine at 
the Paris conference, wrote to Cunningham about his decision to change 
his own treatment to the Semple method.102 He was therefore surprised 
to learn that in Kasauli Cunningham had reverted to using live ether-
ized vaccine, particularly when Hempt himself, following several cases of 
paralysis, had moved to a dead carbolized one.103 It was at this point that 
Cunningham admitted to Prausnitz that he had not known about the 
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Figure 3. Immersed brain matter in ether, Kasauli. Source: J. Cunningham, M. 
J. Nicholas, and B. N. Lahiri, “The Action of Ether on the Rabies Virus,” in Far 
Eastern Association of Tropical Medicine: Transactions of the Seventh Congress Held in 
British India (Calcutta: Thackers Press, 1927), 531–36, 532. Source: Wellcome 
Library, London.
Figure 2. Preparation of Alivisatos’ vaccine in Kasauli. The weighed brain was 
placed on a square of mosquito netting, the four corners of which were caught 
up in a glass hook. It was then suspended in ether. Source: Wellcome Library, 
London, image V0030195. 
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change made by Hempt, although he had clearly learned about it previ-
ously from both McKendrick and Taylor.104
Cunningham now accepted that Hempt used dead vaccines as he had 
found a new hero in Alivisatos, who had apparently not made the shift to 
dead vaccines. From here on Cunningham was more inclined to use the 
Alivisatos method for severe cases. He also refused to use dead carbolized 
vaccines of higher dosage as suggested by others. Instead he now insisted 
that the Indian cases had peculiarities that required a different vaccine, 
insisting ironically that the Semple vaccine was more suited for European 
conditions than for India: “[C]onditions in India are so different to those 
in Europe that the principles laid down in my August note as to the pos-
sibility of using living virus in certain cases still holds good.”105 Later that 
year, Cunningham sent another report to the League of Nations where he 
elaborated the same problem with the new dead vaccine, which required 
much more brain substance, leading to paralytic cases. His preference was 
for live vaccines of lower dosage.106 He also elaborated that while scien-
tists in Europe were trying to standardize dosage for all cases, in Kasauli 
they had adopted a method of classification, giving the high dosage in 
only severe cases.107
The results of these experiments were presented at the Rabies Con-
ference in Calcutta in December 1928, where directors of all the Indian 
Pasteur Institutes met to discuss the future of antirabic policy for India. 
Cunningham presented the results of his experiments with etherized vac-
cines and remained opposed to increasing the dosage of carbolized vac-
cine. He suggested a combination of treatment, etherized living Alivisatos 
vaccine for more severe cases and carbolized for others. He also opposed 
any decentralization.108 He faced severe opposition from other directors. 
William C. H.  Forster, president of the Central Committee, Pasteur Insti-
tute Burma, stressed the immediate need for out centers.109 The terrain 
of a province like Burma made it impossible for patients to travel to Ran-
104. Cunningham to Prausnitz, February 10, 1928, 1–2, ibid.
105. Cunningham to Graham, January 31, 1928, 1–4, ibid.
106. Report by Cunningham to the League of Nations, “Note on Para 2 Letter of July 
14th 1928 from the Medical Director, League of Nations, to the Public Health Commis-
sioner with the Govt of India, Dealing with Resolution No. 11.5 of the International Rabies 
Conference 1927,” 3, E. 19, ibid.
107. Ibid., 4. The Semple vaccine was standardized later, even in India, into a single 
dosage.
108. “Provisional Agenda for Rabies Conference to be Held at Calcutta on 21st Decem-
ber 1928,” 3, ibid.
109. W. H. C. Forster, “A Note on the Present Position of Anti-Rabic Treatment in India” 
1, ibid.
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goon, leading to higher mortality in the provinces. While mortality among 
Rangoon patients was 0.37 percent, that among up-country patients was 
1.07 percent.110 In severe cases, the mortality rates were 1.08 percent and 
5.07 percent, respectively. 111
In the middle of these experiments and debates, there was an abrupt 
end to Cunningham’s pursuance of antirabic research in India. In Feb-
ruary 1929 he left India and went on leave to Edinburgh. R. H. Malone, 
who had assisted him in his researches, took over the investigations.112 In 
1929 Malone produced the first report with results of the experiments 
undertaken by him and Cunningham, which showed that Alivisatos (the 
now live vaccine, according to Cunningham and Malone) gave better 
results than the 5 percent carbolized vaccine, which was in turn better 
than the 5 percent E.C. (etherized–carbolized, Hempt).113 Cunningham 
forwarded a copy of the report to Graham and dismissed the opinion of 
the other directors: “Their opposition simply means that our suggestions 
do not fit in with their preconceived ideas.”114
However, pressure for decentralization with the carbolized vaccine in 
India was mounting. In December 1929 a Medical Research Workers Con-
ference was held in Calcutta where the Rabies Committee, consisting of 
the directors of other Indian Pasteur Institutes like Acton, King, and Tay-
lor, examined an interim report submitted by Malone and Cunningham. 
This report provided a more substantial comparative analysis of Hempt, 
Alivisatos, and Semple vaccines of 5 percent and 2 percent strengths on 
humans (see Table 3).115
So while Alivisatos (live) and Semple (carbolized) showed similar 
results, Hempt’s etherized–carbolized (very dead) vaccines showed the 
worst mortality rates. One point to note is that in these statistics again, and 
in all the subsequent ones, the paralytic cases were ignored altogether. 
In India mortality and severity of bites seemed to have dominated the 
research questions.
There is a need to ask the question, what was a live and what was a 
dead vaccine? In attenuating terms, such categorization between dead 
110. Ibid.
111. Ibid., 2.
112. Cunningham to Secretary, Scientific Advisory Board, Indian Research Fund Asso-
ciation, January 10, 1929, E. 20, ibid.
113. Malone to Cunningham, August 29, 1929, E. 21, ibid.
114. Cunningham to Graham September 19, 1929, ibid.
115. “An Investigation into the Comparative Values of Carbolised and Etherised Vac-
cines in Antirabic Treatment,” Malone’s Interim Report, prepared December 13, 1929, 
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and living vaccines, however, remained vague and often indistinguishable. 
While undertaking these different methods of producing vaccines and 
experimenting with them, Malone identified an interesting phenomenon: 
the line between the live and the dead was not always clear. While Semple 
claimed that the virus in 8 percent suspension of brain was dead after 
incubation at 37°C for twenty-four hours in the presence of 1 percent 
carbolic acid, “but we have shown that it is not the case, for if sufficient 
number of rabbits be subdurally inoculated with 0.2 c.c. of such suspen-
sions approximately 1 in every 125 will contract rabies and presumably 
a greater number would have been infected had we been able to inocu-
late larger quantities.”116 So by this definition, even the Semple vaccine 
contained live viruses that could infect patients. Malone confirmed that 
the good results with 5 percent carbolized was due to higher nerve cell 
content, but even in this vaccine “the possibility of the presence of living 
virus in the 8 percent suspension from which the vaccines were prepared 
cannot be entirely excluded.” Even earlier, in 1926, Cunningham found 
that the Kasauli fixed virus died if immersed in ether for thirty-six hours.117
But in 1927, when he studied the action of ether on Indian “street virus” 
(that collected from infected dog brains sent recently), the virus remained 
alive in central portion of the brain immersed up to seventy-two hours.118
Finally in 1928 he discovered that living virus could be found in infected 
brains after immersion in ether up to eighty-four hours, but not in cords 
exposed to ether for ninety-six hours.119
Even in 1929 Malone had written to Cunningham that he was struck 
by the fact that the “number of brains which contained live virus after 
immersion in ether is greater than the number shown because we have 
not retested the original brains when the first passage animals have died 
without symptoms of rabies.”120 He also referred to the same confusion 
that he mentioned in the report: “[T]he 8% carbolised vaccine is also 
attenuated and not dead as supposed by Semple.”121 Despite these doubts, 
he maintained the conventional distinctions between dead and living vac-
116. Ibid., 18–19.
117. John Cunningham, M. J. Nicholas, and B. N. Lahiri, “The Action of Ether on Fixed 
Virus,” Indian J. Med. Res. 14 (1926): 505–20, esp. 505.
118. Cunningham, Nicholas, and Lahiri, “The Action of Ether on ‘Street Virus’ in 
Infected Brains,” Indian J. Med. Res. 15 (1927): 85–88, esp. 85.
119. Cunningham, Nicholas, and Lahiri, “The Action of Ether on Street Virus on Infected 
Cord,” Indian J. Med. Res. 16 (1928): 245–51, esp. 245.
120. Malone to Cunningham, April 11, 1929, E. 9, JC papers.
121. Ibid.
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cines in the final report and recommended the Alivisatos method, which 
supposedly used live vaccines.122
Other directors of Indian Pasteur Institutes remained strongly opposed 
to the employment of a live vaccine.123 They pointed out that according 
to Malone’s report, while in 1925 the total brain substance used was 0.7 
to 1.95 grams, leading to a mortality of 1.07 percent, in 1926–27, when 
the total brain matter used was 0.7 grams, mortality had risen to 1.39 
percent. From this they drew the conclusion that the real difference in 
the mortality rate was due to the quantity of brain substance and so the 
improvements in the vaccines should be on those lines, rather than using 
a live one.124 They also highlighted that for millions of Indians affected 
by rabies it was better to give them a “stable” vaccine like Semple’s than 
a “freshly prepared non-stable vaccine containing a living virus.” In its 
final resolutions the committee “condemned” the use of a live vaccine 
and stressed that the dead carbolized vaccine should be adopted. It also 
recommended an increase in dosage for severe cases.125 The policy of 
decentralization was supposed to be based on geographical and human 
factors rather than laboratory requirements.126 These recommendations 
and resolutions were subsequently adopted by the GOI and the local 
governments as the official Indian antirabies policy.
The Making of the Semple Vaccine
Antirabic researches soon stopped at the Pasteur Institute in Kasauli. In 
1931 Malone was transferred to Rangoon as the officiating director of the 
122. “An Investigation into the Comparative Values,” E. 21, 19, ibid.
123. Malone to Cunningham, January 9, 1930, E. 21, ibid. Stuart and Krikorian worked 
in the Department of Health Laboratories in Palestine where they conducted experiments 
on both etherized and carbolized (both killed in their opinion) vaccines and concluded that 
the Semple vaccine reduced cases of paralysis. G. Stuart and K. S. Krikorian, “Studies in Anti-
rabies Immunisation,” J. Hygiene 29 (1929): 1–34; “Appearance and Persistence in Rabbits’ 
Blood of Rabicidal Antibodies Produced by Various Methods of Anti-rabies Immunisation,” J. 
Hygiene 31 (1931): 414 –22; and “The Rabicidal Antibody Content of Rabbit Immune Serum 
as an Index of Acquired Resistance to Rabies Infection,” J. Hygiene 32 (1932): 489–93.
124. “Observations by the Directors of Pasteur Institutes of India on the Report by Cun-
ningham and Malone Entitled ‘An Investigation into the Comparative Values of Carbolised 
Vaccine and Etherised Vaccines of Alivisatos and Hempt in Anti-rabic Treatment’ Carried 
Out at the Pasteur Institute, Kasauli,” E. 21, JC papers.
125. “Summary of the Recommendations by Rabies Committee Convened in December 
1929, during the Research Workers Conference at Calcutta, Together with a Copy of Reso-
lution No. 7, Relating to Anti-rabic Treatment in India,” Department of Education Health 
and Land, Health Branch, 1930, 341–44 B, 5, NAI.
126. Ibid., 5–6.
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Pasteur Institute there. In 1939 the Pasteur Institute in Kasauli was closed 
down entirely and all its routine work was transferred to the CRI.127 The 
final report of this project was drawn up by H. E. Shortt at Kasauli, in the 
absence of both Cunningham and Malone (Table 4).128
The report clarified for the first time, that the main variable element 
in the vaccines was the quantity of brain matter: “[T]he better result 
recorded with the 5 per cent vaccines, whether carbolized or etherized, is 
primarily due to the increased dose of brain substance administered and 
not to either the presence of living virus in the vaccine or the preliminary 
treatment of the brain with ether.”129 It should be added that in all these 
statistics, like in the earlier ones, the cases of paralysis were not mentioned 
at all. In India mortality and severity of bites dominated research ques-
tions rather than safety. One observation to make here is that quantities of 
brain matter and degrees of attenuation remaining the same, the results 
were similar. The etherized–carbolized vaccine showed worst results as it 
was much more attenuated. To that extent the Paris question about live 
and dead vaccines now seemed a nonissue. However, this did not erase 
the conventional divides between dead and living vaccines.
By the 1930s the general emphasis of antirabic vaccine research shifted 
from the type of vaccine to the dosage. A report in 1934 by Shortt, Malone, 
and A. C. Craighead pointed out that “the improvement recorded as a 
result of the introduction of the method of Alivisatos was due not to any 
inherent value of the precise details of the method but to the fact that it 
utilized a larger total dose of brain substance. Thus the use of a carbo-
lised 5 per cent rabbit vaccine gave results comparable with Alivisatos’s 
vaccine.”130 It concluded that “[t]he advantage of a higher dosage of brain 
substance . . . thus been established.”131 The British Medical Journal (BMJ), 
while commenting on the 1933 report, considered even Alivisatos’s vac-
cine as dead, along with the Semple and Hempt vaccines, as according to 
it only dried cord vaccines were living ones.132
As a consequence of this consensus, by the late 1930s the dosage of the 
Semple vaccine was increased and standardized. The vaccine now contained 
127. Webster, Rabies and Antirabic Treatment (n. 41), 6.
128. “An Investigation into the Value of an Etherised Vaccine in the Prophylactic Treat-
ment of Rabies,” MSS Drafts, tables relating to work on rabies, E. 22, JC papers.
129. “An Investigation into the Value of an Etherised Vaccine in the Prophylactic Treat-
ment of Rabies,” MSS Drafts, tables relating to work on rabies, table IV, 16–17, E. 22, ibid.
130. H. E. Shortt, R. H. Malone, and A. C. Craighead, “An Investigation into the Relative 
Immunizing Value of the Kasauli and Paris Strains of Rabies Fixed Virus,” Indian Med. Res. 
Mem., Supplementary Series to the Indian J. Med. Res. 28 (1934): 1–78, quotation on 1.
131. Ibid., 2.
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carbolized killed virus of a 5 percent suspension of sheep’s brain.133
Sheep’s brain was first used in 1926 by E. C. R. Fox in Calcutta.134 It was 
adopted as universal for the Semple vaccine in 1934 as it was cheaper to 
use particularly when a higher dosage was standardized and mass vacci-
nation was adopted.135 Decentralization proceeded rapidly, and by 1938 
nearly two hundred out centers were supplied with the Kasauli vaccine 
alone. Similar trends were noticeable in the Madras Presidency too.136 
The Coonoor figures (Table 5) present the entire history of the evo-
lution of the Semple vaccine. The earliest vaccine used in India was Pas-
teur’s dried cord one, which was replaced in 1911 by the original Semple 
vaccine (1 percent carbolized rabbit brain). From 1923 this was replaced 
by the experimental vaccines ranging from 1 percent to 5 percent. From 
the 1930s the standardized Semple vaccine (5 percent sheep brain, car-
bolized) was used exclusively. This was also the period when treatment was 
increasingly decentralized, with more patients treated at the out centers 
than at Coonoor Pasteur Institute.
Yet at the same time there was evidence that all was not right with the 
Semple vaccine. As early as 1930 the BMJ observed that “[a] few com-
plaints were received about the unfavourable effects of antirabic treatment 
on the general condition of health.”137 In 1936 S. D. S. Greval (Calcutta 
School of Tropical Medicine) revisited the almost forgotten question of 
paralysis from antirabic treatment in India in an article titled “Against 
Orthodoxies in Rabies” and provided details of cases of paralysis from 
Semple vaccines.138 He studied cases of paralysis following “intensive 
treatment” or administration of higher doses, which as he pointed out 
was contrary to the “[o]pinion generally held . . . that the incidence of 
133. Cunningham, draft of article, “Rabies,” E. 25, JC papers.
134. R. Knowles, “Anti-rabic Policy in India,” Indian Med. Gazette 65 (1930): 155–56, 
esp. 156.
135. Shortt, Malone, and Craighead, “Investigation into the Relative Immunizing Value” 
(n. 130), 7. Very similar improvements were noticed by Maria J. Otten-van Stockum in Ban- 
dung in the Dutch East Indies with her formalized vaccines prepared from monkey brain in 
1916. She used monkey brain as it was cheaper and provided more brain matter per animal 
than the rabbit. Otten-van Stockum, “Rabies Research in the Netherlands Indies,” reprinted 
from “Rabies Researches,” in Meded. Van den Dienst der Volksgezondesd in Nederlandsch Indie 
30 (1941): 269–79.
136. The Pasteur Institute of Southern India, Coonoor, Thirty Eighth Annual Report (Madras: 
Pasteur Institute of Southern India, 1940), 15.
137. “Progress of Antirabic Treatment,” Brit.  Med. J. 1 (May 1930): 923–24, quotation 
on 924.








































Table 5. Patients treated with antirabies vaccine at the Pasteur Institute, 
Coonoor, between 1907 and 1938
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paralysis is independent of the intensity of treatment.”139 He drew the 
important conclusion that “[c]arbolization of the vaccine does not ward 
off the sequelæ. It would not be necessary at all to state this point if the 
opposite were not so widely believed in India by the general medical pro-
fession.”140 In the annual reports of the Indian Pasteur Institutes in 1940, 
it was noted that Semple’s vaccine, although effective, was also leading to 
cases of serious posttreatment paralysis as they contained large quantities 
of nerve tissues. The reports highlighted the need to produce a vaccine 
with equal potency but free from such nerve tissues.141 However, there 
were few takers for this point of view.
By the 1940s Semple’s vaccine was the celebrated one for antirabic 
treatments all over the world, and as William J. Webster (assistant director 
of CRI) noted in 1943, “Semple’s vaccine is now in general use all over the 






























Table 5. Patients treated with antirabies vaccine at the Pasteur Institute, Coonoor,
between 1907 and 1938. Source: Pasteur Institute of Southern India (n. 136), 15.
Source: Pasteur Institute of Southern India (n. 136), 15.
139. Ibid., 73.
140. Ibid.
141. Pasteur Institute of Southern India (n. 136), 17. Also see N. Veeraraghavan, “Pheno-
lized Vaccine Treatment of People Exposed to Rabies in Southern India,” Bull. WHO 10 
(1954): 789–96.
142. Webster, Rabies and Antirabic Treatment (n. 41), 7.
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He reiterated its virtue: “[I]t is a dead vaccine.”143 However, as explained 
earlier, the actual distinctions between dead and living vaccines remained 
vague and often indistinguishable.
If clear distinctions between live and dead vaccines were untenable, 
how do we understand “laboratory rabies” and its links with the live vac-
cines, an association that was central to the evolution of antirabies vac-
cines? Here once again, we need to go beyond the phrase of “laboratory 
rabies” and understand the true nature of the disease.
Deconstructing Rage du Laboratoire
As noted earlier, “laboratory rabies” was first identified by scientists 
opposed to Pasteur’s methods as a unique disease produced in the labo-
ratory from Pasteur’s vaccines. It was soon adopted by antivivisectionists 
as a powerful moral and methodological critique of Pasteur’s methods. 
Subsequently it was also adopted by historians like Geison, often with 
similar moral and medical connotations.144
However, the etiology of “laboratory rabies” has remained unclear. The 
first problem is to identify whether it is a specific disease or a generic term 
used for several postvaccinal complications and cases of mortality that 
indicated a different failure of treatment. Often the critiques clumped 
the various postvaccinal complications under this single label.145
Moreover, the nature of the paralytic or neurological complications 
caused within the laboratory also remained uncertain. Even in the 1930s 
doubts remained as to the proper etiology of this paralysis. Some held 
that it was due to the nature of street virus used; others argued that it was 
due to the nature of the fixed virus. Tinti considered it an anaphylactic 
phenomenon, while others identified human susceptibility to rabbit brain 
as the chief factor.146 The American Journal of Public Health confirmed this 
ambiguity in 1930: “It is now widely believed to be due to the action of 
some unknown substance contained in the vaccine. We can only accept 
the statement of the Rabies Conference that our knowledge does not 
enable us to make positive assertions as to the etiology.”147 
In 1940 McKendrick produced his extensive antirabies vaccination 
report, which included data from 1,062,707 cases of rabies collected from 
143. Ibid.
144. Geison, “Pasteur, Roux, and Rabies” (n. 6), 358.
145. Gelfand, “Day Medicine Changed” (n. 44), 710.
146. “Antirabic Treatment Paralysis,” Amer. J. Pub. Health 20 (1930): 412–13, esp. 412.
147. Ibid.
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Pasteur Institutes all over the world.148 One important finding was that 
although he had studied a variety of cases treated by both “live” and “dead” 
vaccines, in different laboratories and in different conditions, there was no 
discernible difference in cases of paralysis among patients administered 
different treatments.149 This highlighted for the first time the problem in 
the link between laboratory rabies and live vaccines.150
The question is, was “laboratory rabies” an “artificial” or “experimental” 
form of rabies created in the laboratory as was often supposed, or was it 
the original affliction that the vaccine had failed to treat, or an entirely 
different disease, not a form of rabies? By the 1940s, the postvaccinal 
paralytic cases were defined as a form of encephalitis. In 1949, the Inter-
national Rabies Committee of the World Health Organization (WHO) 
focused on the problem of postvicinal paralysis, the “demyelinating 
lesion” of the cord, and noted that the cases of paralysis were a reaction 
of some constituent of nervous tissue in the vaccine rather than an effect of 
the virus.151 It also added that it was a form of encephalomyelitis.152 Thus, 
the allergic encephalomyelitis was caused not by the rabies virus, live or 
dead. It was a condition not necessarily connected to rabies as it could be 
caused by nonrabid brain matter as well. The agent here was the amount 
of adult brain tissues, and thus such cases could be caused by dead vac-
cines as well, particularly in larger doses. Strictly speaking, it was a different 
paralytic disease, not related to rabies. The same year, Charles Pait and 
Harold Pearson, while studying encephalomyelitis caused by rabies vac-
cines in Los Angeles, concluded that the most clearly identifiable factors 
of postvaccinal paralysis (or “vaccine encephalitis”) were  the indiscrimi-
nate vaccine usage and the presence of brain tissue.153
Despite these findings, “laboratory rabies” remained a sacrosanct dis-
ease, little understood, often feared, but rarely challenged. G. S. Turner 
(Lister Institute of Preventive Medicine) in 1969 characterized postvac-
cinal paralytic cases within two categories. While he accepted the new 
148. McKendrick, “A Ninth Analytical Review of Reports from Pasteur Institutes on the 
Results of Antirabies Treatment,” Bull. WHO 9 (1940–41): 31.
149. Baer, Natural History of Rabies (n. 54), 576.
150. Charles F. Pait and Harold E. Pearson, “Rabies Vaccine Encephalomyelitis in Rela-
tion to the Incidence of Animal Rabies in Los Angeles,” Amer. J. Pub. Health Nation’s Health 
39 (1949): 875–77, esp. 875.
151. “The Treatment of Rabies,” Brit. Med. J. 2 (October 1950): 823–24, esp. 823.
152. F.–X. Meslin and M. M. Kaplan, “General Considerations in the Production and 
Use of the Brain Tissue and Purified Chicken-Embryo Rabies Vaccines for Human Use,” in 
Laboratory Techniques in Rabies, ed. F.-X. Meslin, M. M. Kaplan, and H. Koprowski (Geneva: 
World Health Organization, 1996), 223–33, esp. 224.
153. Pait and Pearson, “Rabies Vaccine Encephalomyelitis” (n. 150), 877.
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findings the “demyelinating lesions” of the central nervous system caused 
by brain tissues of mature animals found in dead vaccines, he also insisted 
that there was another form, which he too referred to as “Laboratory 
rabies,” which was supposedly caused by the living virus.154 However, he 
provided no scientific specification of the nature of the disease and its 
causation. Such demarcations between living and dead vaccines have been 
constantly revisited and reaffirmed. In 1960 eighteen people died in For-
taleza, Brazil, from postvaccinal paralytic complications. The Bulletin of 
WHO described the deaths following rabies vaccination with Fermi-type 
vaccine (which, as the report described, was essentially the Semple vac-
cine, carbolized, 5 percent and from sheep brain) as “Rage de Laboratoire” 
caused by a live vaccine.155 In 1973, the WHO Expert Committee on Rabies 
asserted that no vaccines containing a live virus should be employed in 
human vaccination.156 While doing so, it did not specify any characteristics 
of a virus considered as live or dead. Moreover, it did not ban any higher 
dosage of brain matter or stipulate any limit of dosage, a factor already 
identified with postvaccinal paralysis in its own 1949 report. Not just for 
rabies, the WHO in the 1970s was apprehensive about using “live” plague 
vaccines as well.157 No clear and consistent definition of what was a living 
and what was a dead vaccine has ever been produced.
One important and tangible outcome of this was for the Semple vac-
cine. Once the carbolized vaccine was designated as “dead” and thereby 
safe, higher dosage of brain matter was sanctioned to be injected in it. The 
consequence of this increase has been tragic. The Semple vaccine, which 
until 2001 was the only form of vaccine in the rabies-infected Asian coun-
tries like Pakistan, India, and Bangladesh, was provided free of charge by 
the governments.158 In 2005 the WHO Committee on Rabies noted that 
although the use of Semple vaccine was still widespread, it was responsible 
for severe and long-term side effects. It identified the problem to be in 
the adult brain matter and initially recommended suckling mouse brain 
vaccines and later cell culture and purified duck embryo vaccines.159 This 
154. G. S. Turner, “Rabies Vaccines,” Brit. Med. Bull. 25 (1969): 136–42, esp. 136.
155. Madureira Pará, “An Outbreak of Post-Vaccinal Rabies (Rage de Laboratoire) in For-
taleza, Brazil in 1960,” Bull. WHO 33 (1965): 177–82.
156. WHO Expert Committee on Rabies: Sixth Report (WHO technical report series no. 523; 
Geneva, 1973), 17.
157. Karl F. Meyer, “Effectiveness of Live or Killed Plague Vaccines in Man,” Bull. WHO 
42 (1970): 653–66.
158. Strategies for the Control and Elimination of Rabies in Asia: Report of a WHO Interregional 
Consultation (Geneva: World Health Organization, 2001), 3.
159. WHO Expert Consultation on Rabies (WHO technical report series no. 931; Geneva, 
2005), first report, 13. The suckling mouse brains were first tried in the 1960s for antirabic
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marked a paradigm shift in vaccine research, from the dead/live to the 
adult/embryonic.
Thus, cases of paralysis were not necessarily linked to live or dead 
viruses; they were essentially caused by the quantity of adult nerve mat-
ter in the vaccines. There was no clear divide between living and dead 
vaccine, and no real evidence was available that the etherized vaccine 
was indeed living and carbolized was dead. Rage du laboratoire, as it came 
to be regarded, was essentially a construct that was adopted by the oppo-
nents as well as the proponents of Pasteur. In their imagination it became 
a peculiar form of rabies and was linked to the fear of and fascination 
with the living virus. It became an important concern for Pasteurists in 
Europe as it was a powerful weapon in the armory of the anti-Pasteurians. 
Laboratory rabies and its association with the live vaccine was indeed an 
exercise (in the Kuhnian sense) in the creation of a regime of problems 
and solving them.160
Conclusion
The history of the Semple vaccine shows the convergence of Pasteurian 
paradigm and British imperial bacteriology. More importantly, it shows 
that in these laboratory experiments “living” and “dead” were essentially 
ideological categories. Yet out of these ideological debates and intangible 
constructs the Semple vaccine, which became the most popular antirabies 
vaccine in the world, was produced; millions of patients in Asia, Africa, 
and the Americas were inoculated with it, many were cured, and several 
others died from paralytic complications. 
These complex, intense, and yet abstract debates about live and dead 
vaccines highlight the limitation of Bruno Latour’s hylozoism. Rather 
than questioning Pasteur’s and other bacteriologists’ role in creating the 
divides between the living and the dead, Latour sought to provide the 
same life-like agency to the microbes. In doing so, Latour became part 
of the scientists’ world, which was divided by the ideas of the heroic live 
vaccines and the sterilized dead ones. The viruses themselves, alive or 
dead, had little agency in it.
In essential terms, the equation was that more nerve tissue produced 
better mortality rates but also led to more cases of postvaccinal paralysis. 
vaccine. E. Fuenzalida, R. Palacios, and J. M. Borgonˇo, “Antirabies Antibody Response in Man 
to Vaccine Made from Infected Suckling-Mouse Brains,” Bull. WHO 30 (1964): 431–36.
160. Thomas S. Kuhn, “The Essential Tension: Tradition and Innovation in Scientific 
Research,” in The Philosophy of Science, ed. Richard Boyd, Philip Gasper, and J. D. Trout 
(Cambridge, Mass: MIT Press, 1991), 139–58.
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This was not due to the nature of the vaccine, live or dead. Cunningham 
was right to point out the dangers of the carbolized vaccine, which could 
lead to increased use of nerve cells. His gradation method of vaccination 
according to the severity of cases was also innovative. However, he too was 
caught up in the Pasteurian paradigm of live germs.
Why did such a divide endure for so long and so forcefully? The debates 
around the living and dead were important because they referred to the 
two most important concerns of vaccine research, potency and safety. 
Dead vaccines were identified as safe, stable, and dependable. It was also 
because vaccine research is result oriented, and one way to resolve some 
of the complex problems faced by antirabic vaccination in terms of safety 
and mortality was by creating clear demarcations and identities of diseases 
and their vaccines. These were at the core of the modern understanding 
of “virus,” organically linked to ideas of “virulence.” From Pasteur’s time 
scientists had engaged with the virulence of viruses to produce potent 
antivirus, the fear and fascination with the living and the virulent in a 
world of germs.
Finally, there were ambiguities in the understanding of the living and 
the dead itself in contemporary scientific thinking, an ambiguity that few 
scientists confronted or referred to. A rare and wonderful exposition of 
this came in 1928, from the pathologist and naturalist Arthur E. Boycott 
in his presidential address to the Royal College of Medicine, where he 
spoke about “The Transition from Live to Dead.” He elaborated how in 
nature a polarization between the living and the dead was false. The two 
were in a continuum,
[in] an assemblage of concurring and converging probabilities which encour-
age one to think it possible that things which are alive and things which are 
not alive constitute in effect one series, beginning with hydrogen atoms and 
reaching up to man, and perhaps to angels, not arranged in a continuous 
linear succession but on a scheme resembling the phylogenetic line of the 
animal kingdom. . . . Such a view satisfies our natural antipathy to a dualistic 
explanation of the universe and makes the old controversy about vitalism and 
mechanism largely unnecessary. It tells us nothing about the nature of life; by 
indicating that organisms are analogous to elements, it encourages us to think 
of life as being as insoluble as gravitation. . . . If you like to be paradoxical, 
you can say that live things are dead, or if you prefer it, that dead things are 
alive. Both at bottom have much the same characters, and it is unlikely that 
any sharp distinctions between them can be drawn.161
161. Arthur E. Boycott, “The Transition from Live to Dead: The Nature of Filterable 
Viruses,” Proc. Roy. Soc. Med. 22 (1928): 55–69, quotation on 60.
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